Citation Impact
Citing Papers
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
2010 StandoutScience
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Influence of the Severity of Cognitive Impairment on the Effect of the <i>Ginkgo biloba</i> Extract EGb 761<sup>®</sup> in Alzheimer’s Disease
2002
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Vascular dementia
2015 Standout
The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis
2000
Differential validity of psychometric tests in dementia of the Alzheimer type
1992
Estrogen blocks inducible nitric oxide synthase accumulation in LPS-activated microglia cells
2000
Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: A randomised double-blind, prospective multicentre study
1995
Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research
2005
Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.
1998 Standout
Alzheimer's disease
2011 Standout
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer’s Disease Trials: An AIBL Study
2015 StandoutNobel
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Function and Regulation of CREB Family Transcription Factors in the Nervous System
2002 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts
2010
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci
1999
Results of a Randomized Trial Comparing Sequential Intravenous/Oral Treatment with Ciprofloxacin Plus Metronidazole to Imipenem/Cilastatin for Intra-Abdominal Infections
1996
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
1998 Standout
Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity
2001
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Cerebrospinal Fluid Penetration of High Doses of Intravenous Ciprofloxacin in Meningitis
2000
Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study
2009
Non-Cholinergic Strategies for Treating and Preventing Alzheimer??s Disease
2002
Oxidative stress and Alzheimer disease
2000 Standout
Comparison of Intravenous/Oral Ciprofloxacin Plus Metronidazole Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal Infections
2000
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Comparison of the Alzheimer’s Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in Differentiating Elderly Individuals with Different Degrees of White Matter Changes
2007
Vascular cognitive impairment
2003 Standout
The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia
2000
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
Current Concepts in Mild Cognitive Impairment
2001 Standout
Estrogen Modulates Neuronal Bcl‐xl Expression and β‐Amyloid‐Induced Apoptosis
1999
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
2013 Standout
Depression and Pain Comorbidity
2003 Standout
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
2009
I-TASSER: a unified platform for automated protein structure and function prediction
2010 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Tendon Injury and Tendinopathy
2005 Standout
Production and Actions of Estrogens
2002 Standout
Alzheimer's Disease
2004 Standout
Neurodegenerative diseases and oxidative stress
2004 Standout
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Herbal Medicines and Perioperative Care
2001 Standout
Oral quinolones in hospitalized patients: an evaluation of a computerized decision support intervention*
2004
Infective endocarditis
2004 Standout
Estrogen Actions in the Central Nervous System1
1999 Standout
Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years
2005
<emph type="ital">Ginkgo biloba</emph> for Preventing Cognitive Decline in Older Adults<subtitle>A Randomized Trial</subtitle>
2009
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy
1999
Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration
2006 Standout
Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia
2008
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
The Prevention of Dementia With Antihypertensive Treatment<subtitle>New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study</subtitle>
2002
Enhancing Our Lives with Immersive Virtual Reality
2016 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory
2012
Putting the Alzheimer's cognitive test to the test I: Traditional psychometric methods
2012
The Effect of Ciprofloxacin on Tendon, Paratenon, and Capsular Fibroblast Metabolism
2000
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
De novo synthesis of substituted pyridines
2004 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
2011
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
1997
Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain.
2001
An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT1A Agonist (PRX-00023) for the Treatment of Anxiety and Depression
2006
Pharmacokinetics of Ciprofloxacin and Its Penetration into Bronchial Secretions of Mechanically Ventilated Patients with Chronic Obstructive Pulmonary Disease
2011
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Impact of 6-Month Aerobic Exercise on Alzheimer’s Symptoms
2013
Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT1A Receptors
1999
The ADAS‐Cog revisited: Novel composite scales based on ADAS‐Cog to improve efficiency in MCI and early AD trials
2012
Nonreciprocal homeostatic compensation in Drosophila potassium channel mutants
2017 StandoutNobel
Estrogen for Alzheimer’s disease in women
2000
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Metal-Free Multicomponent Syntheses of Pyridines
2014 Standout
Works of Lee Kaiser being referenced
The Alzheimer's Disease Assessment Scale: Evaluation of Psychometric Properties and Patterns of Cognitive Decline in Multicenter Clinical Trials of Mild to Moderate Alzheimer's Disease
2001
Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily
1994
Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants
1998
The Alzheimer's disease assessment scale
1997
Nimodipine in the Treatment of Probable Alzheimerʼs Disease
1996
Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses
1992